Skip to main content
Explore URMC
menu

Nabeel Badri, M.B.Ch.B.

Contact Information

Phone Numbers

Appointment: (585) 276-3000

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Cancer

Biography

I am a medical oncologist at the Wilmot Cancer Institute, University of Rochester Medical Center. I am specialized in treating gastroenterology malignancies. My primary research interest has focused on gastrointestinal malignancies. Currently, I have been involved in various studies/clinical-trials investigating novel approaches and chemo-therapeutics to treat gastrointestinal cancer.

Conditions I treat:

* Esophageal cancer
* Stomach cancer
* Pancreatic cancer
* Colon cancer
* Rectal cancer
* Anal cancer
* Neuroendocrine tumors and carcinoid tumors
* Liver cancer: Hepatocellular carcinoma (HCC)
* Bile duct cancer
* Cholangiocarcinoma
* Appendiceal cancer and tumors

Credentials

Specialties

  • Internal Medicine - American Board of Internal Medicine
  • Medical Oncology - American Board of Internal Medicine

Education

2007
MBCHB | University of Baghdad, Al-Kindy College of Medicine

Post-doctoral Training & Residency

07/01/2018 - 06/30/2020
Fellowship in Hematology/Oncology at University of Rochester Medical Center

07/01/2017 - 06/30/2018
Fellowship in Hematology/Oncology at Howard University Hospital

07/01/2015 - 06/30/2017
Residency in Internal Medicine at Texas Tech University Health Sciences Center El Paso

07/01/2014 - 06/30/2015
Internship in Internal Medicine at Texas Tech University Health Sciences Center El Paso

VIEW ALL expand_more

Publications

Journal Articles

6/2018
Nahleh Z, Otoukesh S, Mirshahidi HR, Nguyen AL, Nagaraj G, Botrus G, Badri N, Diab N, Alvarado A, Sanchez LA, Dwivedi AK. "Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics." Cancer medicine. 2018 Jun 0; 7(6):2710-2717. Epub 2018 May 07.

2018
Elzamly S, Badri N, Padilla O, Dwivedi AK, Alvarado LA, Hamilton M, Diab N, Rock C, Elfar A, Teleb M, Sanchez L, Nahleh Z. "Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy." Breast cancer : basic and clinical research.. 2018 12:1178223418788074. Epub 2018 Aug 01.

1/24/2017
Montoya A, Amaya CN, Belmont A, Diab N, Trevino R, Villanueva G, Rains S, Sanchez LA, Badri N, Otoukesh S, Khammanivong A, Liss D, Baca ST, Aguilera RJ, Dickerson EB, Torabi A, Dwivedi AK, Abbas A, Chambers K, Bryan BA, Nahleh Z. "Use of non-selective ?-blockers is associated with decreased tumor proliferative indices in early stage breast cancer." Oncotarget.. 2017 Jan 24; 8(4):6446-6460.

VIEW ALL PUBLICATIONS